ROIV Roivant Sciences Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: ROIV

Price (delayed)

$11.43

Market cap

$9.21B

P/E Ratio

2.06

Dividend/share

N/A

EPS

$5.56

Enterprise value

$3.05B

Highlights
Roivant Sciences's revenue has surged by 186% YoY and by 19% QoQ
ROIV's gross profit is up by 23% from the previous quarter
The debt has increased by 6% year-on-year
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of ROIV
Market
Shares outstanding
805.85M
Market cap
$9.21B
Enterprise value
$3.05B
Valuations
Price to earnings (P/E)
2.06
Price to book (P/B)
1.51
Price to sales (P/S)
74.25
EV/EBIT
0.67
EV/EBITDA
0.67
EV/Sales
24.72
Earnings
Revenue
$123.24M
EBIT
$4.55B
EBITDA
$4.58B
Free cash flow
-$838.55M
Per share
EPS
$5.56
Free cash flow per share
-$1.05
Book value per share
$7.58
Revenue per share
$0.15
TBVPS
$8.95
Balance sheet
Total assets
$7.31B
Total liabilities
$728.1M
Debt
$506.58M
Equity
$6.09B
Working capital
$6.56B
Liquidity
Debt to equity
0.08
Current ratio
27.79
Quick ratio
27.24
Net debt/EBITDA
-1.35
Margins
EBITDA margin
3,715.3%
Gross margin
87.6%
Net margin
3,624.1%
Operating margin
3,467.9%
Efficiency
Return on assets
128.5%
Return on equity
196.2%
Return on invested capital
590%
Return on capital employed
64.4%
Return on sales
3,691.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ROIV stock price

How has the Roivant Sciences stock price performed over time
Intraday
1.69%
1 week
3.63%
1 month
-0.7%
1 year
35.43%
YTD
1.78%
QTD
8.44%

Financial performance

How have Roivant Sciences's revenue and profit performed over time
Revenue
$123.24M
Gross profit
$107.92M
Operating income
$4.27B
Net income
$4.47B
Gross margin
87.6%
Net margin
3,624.1%
Roivant Sciences's revenue has surged by 186% YoY and by 19% QoQ
ROIV's gross profit is up by 23% from the previous quarter
The company's gross margin rose by 12% YoY and by 2.8% QoQ

Growth

What is Roivant Sciences's growth rate over time

Valuation

What is Roivant Sciences stock price valuation
P/E
2.06
P/B
1.51
P/S
74.25
EV/EBIT
0.67
EV/EBITDA
0.67
EV/Sales
24.72
The stock's price to book (P/B) is 76% less than its last 4 quarters average of 6.1
Roivant Sciences's revenue has surged by 186% YoY and by 19% QoQ
The stock's price to sales (P/S) is 15% less than its last 4 quarters average of 85.8

Efficiency

How efficient is Roivant Sciences business performance

Dividends

What is ROIV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ROIV.

Financial health

How did Roivant Sciences financials performed over time
ROIV's total liabilities is down by 6% year-on-year
The debt is 92% smaller than the equity
The debt to equity has dropped by 85% since the previous quarter and by 84% year-on-year
The debt has increased by 6% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.